Blog

Personalized Approaches to T1 Colorectal Cancer Treatment

This study explored the optimal management of T1 colorectal cancers (CRCs) in the Western hemisphere. Analyzing a significant dataset from 2004 to 2018, including 28,430 T1 CRC patients, researchers compared endoscopic therapy (ET) and surgical resection (SR) outcomes. They found that ET was safe and effective for left-sided T1N0M0 colon cancers with tumors 2 cm or smaller and T1N0M0 rectal cancers with tumors 1 cm or smaller. The study emphasizes the importance of tailored treatment based on tumor size and location to avoid over- or under-use of ET.

Journal Article by Shi K, Yang Z and Leng K in Front Med (Lausanne)

Copyright © 2023 Shi, Yang and Leng.

read the whole article in Front Med (Lausanne)

open it in PubMed

MRE Model Predicts Hepatic Decompensation in NAFLD Patients

A multicenter study harnessed Magnetic Resonance Elastography (MRE) to create a prediction model for hepatic decompensation in Non-Alcoholic Fatty Liver Disease (NAFLD) patients. This model, which combines MRE data with clinical factors like age, albumin, aspartate aminotransferase, and platelets, demonstrated excellent accuracy in forecasting the risk of hepatic decompensation over 3- and 5-year periods. The MRE-based model outperformed the Fibrosis-4 model, offering a promising tool for risk assessment and management in NAFLD patients.

Journal Article by Kim BK, Bergstrom J (…) Ajmera V et 13 al. in Hepatology

Copyright © 2023 American Association for the Study of Liver Diseases.

read the whole article in Hepatology

open it in PubMed

Modified Rutgeerts Score Predicts Recurrence in Crohn’s Disease Patients

In a study involving 652 patients who underwent primary ileocecal resection for Crohn’s disease, the Modified Rutgeerts Score (MRS) proved to be a valuable predictor of long-term outcomes. Patients with higher MRS values were more likely to experience surgical and clinical recurrence, as well as progression to severe endoscopic recurrence. Specifically, an MRS of i2b or higher correlated with surgical recurrence, i1 or i2b with clinical recurrence, and i1 or i2b with progression to severe endoscopic recurrence. These findings emphasize the importance of closely monitoring disease activity and optimizing treatment strategies in Crohn’s patients.

Journal Article by Bak MTJ, Ten Bokkel Huinink S (…) de Vries AC et 11 al. in Am J Gastroenterol

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.

read the whole article in Am J Gastroenterol

open it in PubMed

Neoadjuvant Therapy Benefits Esophageal Adenocarcinoma Patients

In a study involving 3,413 patients with cT2N0M0 esophageal adenocarcinoma, researchers investigated the impact of neoadjuvant chemoradiotherapy (NT) on surgical outcomes and oncological benefits for those with clinical stage IIA disease. The study found that NT did not adversely affect perioperative outcomes compared to upfront surgery. Moreover, minimally invasive esophagectomy after NT was feasible, and NT was associated with improved survival, particularly in patients with larger tumors (>5 cm). This study suggests that NT is a valuable option for selected cT2N0M0 esophageal adenocarcinoma patients.

Journal Article by Rodriguez-Quintero JH, Kamel MK (…) Stiles BM et 4 al. in Ann Surg Oncol

© 2023. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Noninvasive Approach Accurately Detects Crohn’s Disease Recurrence

A study conducted in three Italian referral centers assessed the accuracy of a noninvasive approach for detecting postoperative recurrence (POR) in Crohn’s disease. Colonoscopy, the standard method for POR assessment, can be invasive and poorly tolerated. The study found that a combination of bowel ultrasound and fecal calprotectin levels reliably detected POR without the need for colonoscopy. This noninvasive approach, incorporating factors like bowel wall thickness and mesenteric lymph nodes, provides an alternative for monitoring patients with Crohn’s disease after surgery.

Journal Article by Furfaro F, D’Amico F (…) Allocca M et 12 al. in Clin Gastroenterol Hepatol

Copyright © 2023 AGA Institute. Published by Elsevier Inc. All rights reserved.

read the whole article in Clin Gastroenterol Hepatol

open it in PubMed

Marking Small Liver Tumors Before Surgery: Will It Improve Resection?

To enhance the precision of small liver tumor removal, a phase II study in Japan will evaluate preoperative marking’s effectiveness. Patients with liver tumors ≤15 mm requiring hepatectomy will undergo microcoil placement near the tumor using either the percutaneous or transvascular approach. The study aims to determine the successful resection rate, with secondary endpoints including the outcomes of preoperative marking and hepatectomy. Results will inform whether preoperative markings benefit curative resection in these cases.

Journal Article by Fukuhara S, Kuroda S (…) Ohdan H et 14 al. in BMJ Open

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

read the whole article in BMJ Open

open it in PubMed

Japanese Study Highlights Trends in Penetrating Injuries and Mortality

A 10-year retrospective study in Japan examined penetrating injuries, their characteristics, and long-term mortality trends among 313,643 patients. The findings showed that while in-hospital mortality rates decreased over the study period, the severity-adjusted mortality trend didn’t significantly improve. Stab wounds remained the primary cause of penetrating injuries. Notably, patients with active bleeding who underwent urgent transcatheter arterial embolization had significantly lower mortality risk. However, surgical procedures for haemostasis didn’t reduce mortality risk for patients with stab wounds and active bleeding. This study emphasizes the need for targeted trauma care strategies.

Journal Article by Nagao T, Toida C and Morimura N in BMJ Open

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

read the whole article in BMJ Open

open it in PubMed

Which Blood Thinners Are Safer for Gastrointestinal Hemorrhage in Atrial Fibrillation?

A systematic review and meta-analysis of real-world studies examined the safety of direct oral anticoagulants (DOACs) in patients with non-valvular atrial fibrillation who experience gastrointestinal hemorrhage (GIH). Apixaban showed a lower risk of GIH compared to dabigatran, rivaroxaban, and vitamin K antagonists (VKA). Rivaroxaban was associated with an increased risk of GIH compared to dabigatran and VKA. Dabigatran had a similar GIH risk to VKA. These findings provide valuable insights for clinicians choosing the right anticoagulant for patients with atrial fibrillation at risk of GIH.

Journal Article by Archontakis Barakakis P, Kokkinidis DG (…) Ntaios G et 6 al. in J Clin Gastroenterol

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

read the whole article in J Clin Gastroenterol

open it in PubMed

Endoscopic Ultrasound-guided Nerve Block Shows Promise in Easing Pancreatic Cancer Pain

In a network meta-analysis of ten randomized controlled trials, researchers assessed the effectiveness of endoscopic ultrasound-guided celiac plexus neurolysis (EUS-CPN) in addition to medical management for abdominal pain in unresectable pancreatic cancer. Results favored EUS-CPN combined with medical management, showing significantly reduced pain intensity at 4 and 12 weeks compared to medical management alone or other techniques like percutaneous CPN. While promising, the study acknowledges the need for cautious interpretation due to potential bias in the analyzed trials.

Journal Article by Okita M, Otani K and Matsui S in J Clin Gastroenterol

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

read the whole article in J Clin Gastroenterol

open it in PubMed

Pancreatic Cancer on the Rise Globally: Factors and Future Projections

Researchers analyzed data from 2020 to 2040 to understand the trends in pancreatic cancer (PC) incidence and mortality worldwide. PC is linked to higher socioeconomic status, with Asia, especially China, bearing the greatest burden. Among age groups, those aged 65 and older are most affected, except in countries with medium and low human development indices where younger populations are at risk. In certain countries, females are more affected. Disturbingly, PC incidence and mortality are predicted to increase by over 60% by 2040, making it crucial to develop targeted strategies and public health policies.

Journal Article by Sharma P, Vuthaluru S, Chowdhury S and Are C in J Surg Oncol

© 2023 Wiley Periodicals LLC.

read the whole article in J Surg Oncol

open it in PubMed